..

Zeitschrift für Infektionskrankheiten und Medizin

Manuskript einreichen arrow_forward arrow_forward ..

Effector-independent in vivo Activity of a Strong Influenza B Neuraminidase Widely Neutralizing Antibody

Abstract

Manuel Gellar

Influenza B virus poses a significant public health threat, particularly during seasonal outbreaks. Traditional treatments and vaccines have limited efficacy against diverse and evolving strains. In this context, antibodies targeting conserved viral components offer a promising therapeutic avenue. This article delves into the effector-independent in vivo activity of a robust influenza B neuraminidase (NA) widely neutralizing antibody (WNA). We explore the antibody’s mechanism, efficacy, and potential implications for future influenza therapies. Our literature review examines previous research on NA-targeting antibodies, while the discussion considers the antibody's therapeutic potential, advantages, and limitations. The conclusion highlights the significance of these findings in the broader context of influenza management.

Teile diesen Artikel

arrow_upward arrow_upward